Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation.
An increasing body of evidence from both animal models and human specimens suggests that apoptosis or programmed cell death is a major event in the pathophysiology of atherosclerosis. Although the significance of apoptosis in atherosclerosis remains unclear, it has been proposed that apoptotic cell death contributes to plaque instability, rupture and thrombus formation. Biochemical and genetic analyses of apoptosis provide an increasingly detailed picture of the intracellular signaling pathways involved. Nevertheless, it remains to be determined whether apoptosis can become a clinically important approach to modulate plaque progression. In this review, we have outlined some of the most recent results concerning apoptosis in atherosclerosis with a special focus on oxidized lipids, inflammation and therapeutic regulation of the apoptotic cell death process.
Martinet
W
W
Division of Pharmacology, University of Antwerp, Wilrijk, Belgium.
Kockx
M M
MM
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001161:Arteriosclerosis / Q000503:physiopathology*; D005487:Foam Cells / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D050356:Lipid Metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism* / Q000494:pharmacology; D018384:Oxidative Stress / Q000502:physiology*; D013812:Therapeutics
D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein